Centre for Biomedical Ethics and Law, K.U. Leuven, Kapucijnenvoer 35, PO Box 7001, 3000 Leuven, Belgium.
Eur J Pediatr. 2010 Dec;169(12):1541-8. doi: 10.1007/s00431-010-1268-6. Epub 2010 Jul 29.
In the course of the past decades, considerable effort has been expended on the ethical guidance and legal regulation of pediatric clinical trials in Europe. Nonetheless, the conduct of clinical research in the population of minors continues to generate myriad ethical and regulatory issues. This paper explores seven bottlenecks in the ethical guidance and legal regulation that currently govern pediatric clinical research: (1) the integration of research in therapy, (2) the education of clinicians, (3) the empowerment of families, (4) the harmonization of protocol review, (5) the assessment non-clinical research objectives, (6) the control of placebo use, and (7) the provision of fair incentives for pediatric research conduct. For all of these issues, a clear view on the way forward is largely lacking, either because these issues have not been discussed in depth to date or because the existing debates have failed to generate a generally supported consensus.
在过去几十年中,欧洲在儿科临床试验的伦理指导和法律监管方面投入了相当大的努力。尽管如此,未成年人临床研究的开展仍然引发了无数伦理和监管问题。本文探讨了目前规范儿科临床研究的伦理指导和法律监管中的七个瓶颈:(1)研究与治疗的结合,(2)临床医生的教育,(3)家庭的赋权,(4)方案审查的协调,(5)非临床研究目标的评估,(6)安慰剂使用的控制,以及(7)为儿科研究提供公平的激励。对于所有这些问题,目前都缺乏明确的前进方向,要么是因为这些问题迄今尚未深入讨论,要么是因为现有的争论未能形成普遍支持的共识。